<?xml version="1.0" encoding="UTF-8"?>
<p id="para0053">
 <italic>Artemisia scoparia</italic> Waldst. &amp; Kit. (redstem wormwood) is widely distributed in Southwest Asia and central Europe
 <italic>.</italic> This species has been reported to possess anti-obesity (
 <xref rid="bib0103" ref-type="bibr">Richard et al., 2014</xref>) and hypolipidemic (
 <xref rid="bib0014" ref-type="bibr">Boudreau et al., 2018</xref>) properties. 
 <italic>A. scoparia</italic> ethanolic extract reduces non-alcoholic fatty liver disease by enhancing hepatic insulin and AMP-AMPK signaling in diet-induced obese mice (
 <xref rid="bib0130" ref-type="bibr">Wang et al., 2013</xref>). 
 <italic>A. scoparia</italic> hot water extract reduces blood pressure in spontaneously hypertensive rats via the inhibition of plasma angiotensin I-converting enzyme (ACE) activity (
 <xref rid="bib0026" ref-type="bibr">Cho et al., 2015</xref>). The phytochemical analysis of this extract revealed that seven SLns contribute to the antihypertensive effect inhibition of ACE activity, highlighting the activity of scoporanolide (
 <bold>19</bold>) and estafiatin (
 <bold>20</bold>) (
 <xref rid="fig0002" ref-type="fig">Fig. 2</xref>) (
 <xref rid="bib0025" ref-type="bibr">Cho et al., 2016</xref>) showing significantly higher ACE inhibitory activities than the other isolated SLns. No 
 <italic>in vivo</italic> toxicity studies on scoporanolide (
 <bold>19</bold>) and estafiatin (
 <bold>20</bold>) have been reported to date.
</p>
